- How it works
- Beyond current advisory AI, this represents the evolution toward AI systems that not only recommend but also monitor, adjust, and learn from clinical outcomes in real time. In ICU settings, AI adjusts ventilator parameters, titrates medications, and manages fluid balance based on continuous physiological monitoring. In chronic disease management, AI adjusts medication doses based on continuous glucose monitoring, blood pressure data, and patient-reported outcomes. Closed-loop systems create feedback cycles where treatment outcomes improve the AI’s future recommendations.
- Impact
- ICU length of stay reduced by 10-20%. Medication errors reduced by 30-50%. Glycaemic control in diabetic patients improved by 25-40% with AI-managed insulin delivery. Treatment personalisation at a scale impossible with human-only management.
- Tools
-
Philips IntelliVue with AIMedtronic AI-assisted insulin deliveryIDx-DR (autonomous diabetic retinopathy diagnosis)GE Healthcare Command Centre
- Roles touched
-
engineeringleadership